ANTICUERPO MONOCLONAL PARA LA DETECCIÓN INMUNOHISTOQUÍMICA CUALITATIVA DE CD8
Mexico·Clase II·III. Agentes de
diagnóstico·PRODUCTOS ROCHE, S.A.
DE C.V.·Registered April 19, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- CONFIRM ANTI- CD8 (SP57) RABBIT MONOCLONAL PRIMARY ANTIBODY
- Trade Name (English)
- CONFIRM ANTI- CD8 (SP57) RABBIT MONOCLONAL PRIMARY ANTIBODY
- Analysis ID
- 1126R2024 SSA
- Registration Date
- April 19, 2024
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DE C.V.
Access comprehensive regulatory information for ANTICUERPO MONOCLONAL PARA LA DETECCIÓN INMUNOHISTOQUÍMICA CUALITATIVA DE CD8 (ANTICUERPO MONOCLONAL PARA LA DETECCIÓN INMUNOHISTOQUÍMICA CUALITATIVA DE CD8) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1126R2024 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on April 19, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.